Boehringer Ingelheim & Trupanion Announce Exclusive Collaboration to Increase Access to Pet Care
June 12 2024 - 9:30AM
Business Wire
Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical
insurance for cats and dogs in North America, and Boehringer
Ingelheim, one of the largest innovators in animal disease
prevention and treatment globally, today announced a strategic
collaboration to provide pets and their families increased access
to high-quality healthcare and enhanced disease treatment and
protection.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240612615100/en/
Both companies have strong commitments to caring for pets
throughout their lifetime. This collaboration will allow them to
leverage their collective expertise and data to derive insights
which will enable the early detection of risk factors for common
conditions affecting pets. Ultimately, this will support earlier
detection and better management of diseases. The two companies will
work together on continuing veterinarian and consumer education,
product extensions, promotions, peer-reviewed publications, and
other efforts in support of pet healthcare.
“We are excited to work with Trupanion because they are so
closely aligned with our mission of creating a world where pets and
those who care for them thrive,” said Daniel Watkins, who leads the
Boehringer Ingelheim Pet business. “Our dedication to driving
industry-leading advancements in animal disease treatments and
prevention is a perfect complement to Trupanion’s best-in-class
product, which increases access to exceptional care and helps pet
caregivers protect their beloved pets throughout their life. By
working together, we will open new doors in the animal health
industry for the veterinary community and pet owners alike.”
This collaboration means that when a pet is enrolled with
Trupanion, their families will be able to opt in to receive
dedicated information and support from Boehringer to help them
manage their pet’s health in the best possible way. In addition,
Boehringer will look to support Trupanion’s goal of ensuring all
pets receive the best medical care possible through its vast
veterinary relationships. Boehringer Ingelheim and Trupanion are
both fully committed to supporting veterinarians, pets and their
families through every step of their lifetime of care.
Trupanion's market-leading growth stems from the difference it
brings to the industry and its solution for unexpected costs of
care. As the only pet medical insurance provider able to pay
veterinarians directly at checkout in seconds, Trupanion eliminates
the need for pet parents to submit a claim and wait for
reimbursement. This allows families and veterinary hospitals to
focus on pursuing the best treatment options instead of financial
hurdles. With unlimited payouts for life, unique lifetime pricing,
and 24/7/365 live support, Trupanion provides families and their
pets with support when they need it most and has proudly paid
nearly $3 billion in veterinary invoices on behalf of its members.
With inflation, human-quality medical advancements, and other
factors spurring historic increases to the cost of veterinary care,
the need for high-quality, comprehensive medical insurance for pets
has never been greater.
“We're thrilled and humbled that Boehringer chose us as a
partner. With this relationship, lifetime care meets lifetime
coverage at a time when pet parents need us more than ever,” said
Dr. Steve Weinrauch, BVMS, MRCVS, Chief Veterinary and Product
Officer at Trupanion. “We couldn’t be more excited for the new ways
we’ll be able to support pets, pet parents and the veterinary
community through this collaboration moving forward.”
About Boehringer Ingelheim Animal Health USA
Boehringer Ingelheim Animal Health is working on first-in-class
innovation for the prediction, prevention, and treatment of
diseases in animals. For veterinarians, pet owners, producers, and
governments in more than 150 countries, we offer a large and
innovative portfolio of products and services to improve the health
and well-being of companion animals and livestock.
As a global leader in the animal health industry and as part of
the family-owned Boehringer Ingelheim, we take a long-term
perspective. The lives of animals and humans are interconnected in
deep and complex ways. We know that when animals are healthy,
humans are healthier too. By using the synergies between our Animal
Health and Human Pharma businesses and by delivering value through
innovation, we enhance the health and well-being of both.
About Trupanion
Trupanion is the leading provider of medical insurance for over
1,000,000 cats and dogs throughout the United States, Canada,
Europe, Puerto Rico and Australia. For over two decades, Trupanion
has given pet owners peace of mind so they can focus on their pet's
recovery, not financial stress. With its patented process,
Trupanion is the only North American provider with the technology
to pay veterinarians directly in seconds at the time of checkout.
Trupanion is listed on NASDAQ under the symbol "TRUP". The company
was founded in 2000 and is headquartered in Seattle, WA. Trupanion
policies are issued, in the United States, by its wholly-owned
insurance entity American Pet Insurance Company and, in Canada, by
Accelerant Insurance Company of Canada. Trupanion Australia is a
partnership between Trupanion and Hollard Insurance Company. For
more information, please visit trupanion.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934 relating to,
among other things, expectations, plans, prospects and
collaborative partnering efforts. These forward-looking statements
are based upon current expectations and beliefs as of the date of
this press release, and are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those described. In particular, development and execution of
collaborative activity could be delayed or changed as efforts
continue. For a detailed discussion of risks and uncertainties with
respect to Trupanion and its business, please refer to the risk
factors discussed in filings with the Securities and Exchange
Commission (SEC), including but not limited to, Trupanion’s Annual
Report on Form 10-K for the year ended December 31, 2023 and any
subsequently filed reports on Forms 10-Q, 10-K and 8-K.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240612615100/en/
Boehringer Ingelheim Brett Israel Director, PR and
Communications, U.S. Pet brett.israel@boehringer-ingelheim.com
Trupanion Laura Bainbridge Senior Vice President,
Corporate Communications Corporate.Communications@trupanion.com
Trupanion (NASDAQ:TRUP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Trupanion (NASDAQ:TRUP)
Historical Stock Chart
From Jul 2023 to Jul 2024